A Little More
about myself

BI

BI

This is actually my surname, but I go by this due to Chinese tradition.
In my generation, we skipped the generation character so I only have two characters [*].
Hence, I am referred to as Bi Mian and abbreviated as "Bi"

Bi is pronounced "Bee"
like the insect

MEDICAL CV

Experience

2019 - Present

Cofounder & Lead Investor

Australian Medical Angels
A clinician led angel investing syndicate investing in
Healthtech & Medtech startups in Australia and beyond.

2018 - Present

Managing Director

Regional Specialists Tamworth
Operator of a multi-specialists centre in Tamworth NSW

with over a dozen specialties and 20 different specialists.

2015 - Present

Emergency Medicine Doctor

Multiple hosptials across NSW

Locum across multiple metropolitan, regional and rural EDs

in CMO, registrar and SRMO roles across the years

2013 - 2014

Registrar / SRMO

Sydney Local Health District, Sydney

Multiple surgical and critical care units in Sydney

including General Surgery, Urology, Vascular, ICU

2012

Resident

Alfred Hospital, Melbourne

Trauma unit, Emergency, Neurosurgery and Urology

2011

Intern

Monash Health, Melbourne

Core rotations across Southeastern Melbourne

Psychiatry & Geriatrics

Education

2018

Doctor of Philosophy

University of New South Wales

Doctoral thesis titled: Genetic factors in excitotoxicity and stroke

2012

Postgraduate Diploma of Surgical Anatomy

University of Melbourne
Special focus on head and neck anatomy

2010

MBBS (Honours)

University of Sydney

Central Clinical School – Royal Prince Alfred Hospital

2006

Bachelor of Medical Science

University of Sydney

Majors in Anatomy, Pathology & Neuroscience

ScholarshipS

NHMRC Postgraduate Scholarship

University of New South Wales

The Role of Tau in Stroke

International Merit Scholarship

University of Sydney

Bachelor of Medical Science

RESEARCH CV

EXPERIENCE

2020 - Present

Honorary Research Fellow

Dementia Research Centre

Macquarie University

2014 - 2018

Doctor of Philosophy

Dementia Research Unit

University of New South Wales

2013 - 2014

Affiliate Researcher

Dementia Research Unit

University of New South Wales

2008 - 2010

MBBS Honours Student

Translational Neurodegeneration Laboratory

University of Sydney

2006 - 2008

Part-Time Research Assistant

Alzheimer’s & Parkinson’s Disease Laboratory

University of Sydney

techniques

Molecular Biology

Proficient: PCR, cloning, bacterial transformation, transfection, cell culture, primary culture, sequencing, immunoblotting, Experience: Western blotting, mass spectroscopy, flow cytometry, transcriptome and whole genome sequencing and analysis.

Virology

Proficient: Lentiviral & adeno-associated virus design, production and purification. Utilising viral vectors for genetic manipulation of animals and cell culture.

Histology & Pathology

Proficient: Tissue handling, preparation, immunohistochemisty, standard microscopy, image processing and analysis

Experience: Confocal imaging, batch imaging processing and analysis.

Mouse models

Proficient: Animal husbandry and handling. Small animal micro-surgery. Small animal anaesthesia. Establishing pharmacological and surgical models of disease.

Experience: Behavioural testing. Drug testing.

Data Science

Proficient: Data strategy, exploratory analysis and modelling. Visualisation and communications.

Experience: Machine learning. Shiny

Software: R, RStudio, Google Sheets

GRANTS

 

MRFF Genomics Health Futures Mission 

Prof Beverley Vollenhoven, Dr Vinayak Smith, Dr Rui Wang, Dr Mian Bi, Prof David Coman, Prof David Gardner, Ms Franca Agresta, A/Prof Gavin Sacks, Dr Fabrizzio Horta, Dr Hua Lin 

Assessing the clinical impact of pharmacogenomics in IVF using a novel clinical decision support system integrating whole genome sequencing and artificial intelligence 
(Monash University)

 


LaunchVic Angel Networks HealthTech

Dr Amandeep Hansra, Dr Mian Bi
 
Increase access to early-stage capital by Victorian HealthTech Startups and the number of informed and active early-stage investors through formalised HealthTech Angel Network (Australian Medical Angels)



NHMRC Ideas Grant

Dr Ole Tietz, Dr Mian Bi, Prof Katherine Vallis


Intraneuronal immunotherapy to treat Alzheimer’s Disease (
Macquarie University)  
 
 

BIBLIOGRAPHY

2022

Loss of LAMP5 interneurons drives neuronal network dysfunction in Alzheimer’s disease
Y Deng, M Bi, F Delerue, SL Forrest, G Chan, J van der Hoven et al.
Acta Neuropathologica 144 (4), 637-650

 

2021

Syntaxins 6 and 8 facilitate tau into secretory pathways
WS Lee, DCS Tan, Y Deng, A van Hummel, S Ippati, C Stevens et al.
Biochemical Journal 478 (7), 1471-1484

 

2019

CNS cell type–specific gene profiling of P301S tau transgenic mice identifies genes dysregulated by progressive tau accumulation

YD Ke, G Chan, K Stefanoska, C Au, M Bi, J Müller, M Przybyla, A Feiten et al.
Journal of Biological Chemistry 294 (38), 14149-14162
 

2018

Selective spatiotemporal vulnerability of central nervous system neurons to pathologic TAR DNA-binding protein 43 in aged transgenic mice

A van Hummel, G Chan, J van der Hoven, M Morsch, S Ippati, L Suh, M Bi et al.
The American Journal of Pathology 188 (6), 1447-1456
 

The importance of early immunotherapy in patients with faciobrachial dystonic seizures

J Thompson, M Bi, AG Murchison, M Makuch, CG Bien, K Chu et al.
Brain 141 (2), 348-356
 

2017

Tau exacerbates excitotoxic brain damage in an animal model of stroke

M Bi, A Gladbach, J Van Eersel, A Ittner, M Przybyla, A Van Hummel et al.
Nature Communications 8 (1), 1-15
 

2016

Site-specific phosphorylation of tau inhibits amyloid-β toxicity in Alzheimer’s mice

A Ittner, SW Chua, J Bertz, A Volkerling, J van der Hoven, A Gladbach et al.
Science 354 (6314), 904-908
 

No Overt Deficits in Aged Tau-Deficient C57Bl/6.Mapttm1(EGFP)Kit GFP Knockin Mice

A Van Hummel, M Bi, S Ippati, J Van Der Hoven, A Volkerling, WS Lee et al.
PLoS One 11 (10), e0163236
 

Disinhibition-like behavior in a P301S mutant tau transgenic mouse model of frontotemporal dementia

M Przybyla, CH Stevens, J van der Hoven, A Harasta, M Bi, A Ittner et al.
Neuroscience Letters 631, 24-29
 

2015

Short-term suppression of A315T mutant human TDP-43 expression improves functional deficits in a novel inducible transgenic mouse model of FTLD-TDP and ALS

YD Ke, A van Hummel, CH Stevens, A Gladbach, S Ippati, M Bi, WS Lee et al.
Acta Neuropathologica 130 (5), 661-678
 

2014

ERK inhibition with PD184161 mitigates brain damage in a mouse model of stroke

A Gladbach, J van Eersel, M Bi, YD Ke, LM Ittner. 
Journal of Neural Transmission 121 (5), 543-547
 

2012

An unusual presentation of recurrent pneumonia

C Cao, M Bi, N Hendel, TD Yan.
The Lancet 379 (9811), 192
 

2011

Cytoplasmic accumulation and aggregation of TDP-43 upon proteasome inhibition in cultured neurons

J van Eersel, YD Ke, A Gladbach, M Bi, J Götz, JJ Kril, LM Ittner.
PloS One 6 (7), e22850
 

2010

Dendritic function of tau mediates amyloid-β toxicity in Alzheimer’s disease mouse models

LM Ittner, YD Ke, F Delerue, M Bi, A Gladbach, J van Eersel, H Wölfing et al.
Cell 142 (3), 387-397
 

2009

Phosphorylation of soluble tau differs in Pick’s disease and Alzheimer’s disease brains

J van Eersel, M Bi, YD Ke, JR Hodges, JH Xuereb, GC Gregory et al.
Journal of Neural Transmission 116 (10), 1243-1251
 

2008

Parkinsonism and impaired axonal transport in a mouse model of frontotemporal dementia

LM Ittner, T Fath, YD Ke, M Bi, J Van Eersel, KM Li, P Gunning, J Götz. 
Proceedings of the National Academy of Sciences 105 (41), 15997-16002